Literature DB >> 23318046

Diagnostic value of CSF findings in antibody-associated limbic and anti-NMDAR-encephalitis.

Michael P Malter1, Christian E Elger, Rainer Surges.   

Abstract

PURPOSE: In people with suspected inflammatory CNS disease, cerebrospinal fluid (CSF) is commonly analyzed. Antibody-associated limbic encephalitis (ab-LE) and anti-NMDAR-encephalitis are recognized as two major syndromes of autoimmune epilepsies. Here, we investigated the diagnostic value of CSF findings in these two entities.
METHODS: We reviewed patients from our tertiary epilepsy centre with ab-LE and anti-NMDAR-encephalitis in whom CSF examination including oligoclonal bands (OCB) was performed. Ab-LE patients were subdivided according to antibodies (voltage-gated potassium channels, VGKC; glutamic acid decarboxylase, GAD) or presence of onconeural antibodies/presence of tumour into three groups: VGKC-LE, GAD-LE or paraneoplastic LE (PLE). As controls, patients with CSF investigations in whom autoimmune origin was initially assumed but not confirmed later on were included. In addition, a review of published ab-LE and anti-NMDAR-encephalitis cases with reported CSF data was performed.
RESULTS: 55 ab-LE (23 VGKC-LE, 25 GAD-LE, 7 PLE) and 14 anti-NMDAR-encephalitis patients were identified at our centre. OCB were significantly more frequent in ab-LE and anti-NMDAR-encephalitis than in controls. Literature review identified 150 ab-LE and 95 NMDAR cases. Analysis of pooled data confirmed that presence of OCB was significantly more frequent in ab-LE and anti-NMDAR-encephalitis (especially in people with GAD-LE and anti-NMDAR encephalitis) as compared to controls. Sensitivity and specificity of OCB in the pooled ab-LE and anti-NMDAR-encephalitis patients was 34% and 96%, respectively. In patients with ab-LE and anti-NMDAR-encephalitis, the likelihood of OCB in CSF was 8.5-fold higher as compared to controls. Furthermore, in the pooled ab-LE and anti-NMDAR-encephalitis patients, cell counts in CSF were more frequently elevated (especially in those with anti-NMDAR encephalitis) than in controls, whereas protein content of CSF was not different between the groups.
CONCLUSION: OCB, and to a lesser extent cell counts in CSF, appear to be helpful additional CSF markers in the diagnostic evaluation of people presenting with a constellation suggestive for GAD-LE, PLE and anti-NMDAR-encephalitis, prompting subsequent analysis of specific antibodies.
Copyright © 2012 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23318046     DOI: 10.1016/j.seizure.2012.12.013

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  16 in total

Review 1.  Diagnosing autoimmune limbic encephalitis.

Authors:  Adrian Budhram; Andrew Leung; Michael W Nicolle; Jorge G Burneo
Journal:  CMAJ       Date:  2019-05-13       Impact factor: 8.262

2.  Clinical Characteristics and Follow-up of South Indian Children with Autoimmune Encephalopathy.

Authors:  Yeeshu Singh Sudan; K P Vinayan; Arun Grace Roy; Amarjeet Wagh; Sudheeran Kannoth; Sandeep Patil
Journal:  Indian J Pediatr       Date:  2016-04-18       Impact factor: 1.967

Review 3.  Advances in Autoimmune Epilepsy Associated with Antibodies, Their Potential Pathogenic Molecular Mechanisms, and Current Recommended Immunotherapies.

Authors:  Zhiwei Fang; Yunqi Yang; Xuan Chen; Weiwang Zhang; Yangmei Xie; Yinghui Chen; Zhenguo Liu; Weien Yuan
Journal:  Front Immunol       Date:  2017-04-25       Impact factor: 7.561

Review 4.  Review of paraneoplastic syndromes in children.

Authors:  Grace My Ma; Jeanne S Chow; George A Taylor
Journal:  Pediatr Radiol       Date:  2019-03-16

5.  The Expression and Significance of the Plasma Let-7 Family in Anti-N-methyl-D-aspartate Receptor Encephalitis.

Authors:  Jing Zhang; Xiaoge Xu; Shaoyun Zhao; Zhe Gong; Peidong Liu; Wenjuan Guan; Xia He; Tianshu Wang; Tao Peng; Junfang Teng; Yanjie Jia
Journal:  J Mol Neurosci       Date:  2015-01-22       Impact factor: 3.444

6.  Anti-N-methyl-D-aspartate receptor encephalitis: a prospective study focused on cerebrospinal fluid and clinical symptoms.

Authors:  Shouyi Wu; Huiqin Li; Yajun Lian; Yuan Chen; Yake Zheng; Chengze Wang; Qiaoman Zhang; Zhi Huang; Zhengrong Mao; Kai Pang
Journal:  Neurol Sci       Date:  2020-05-12       Impact factor: 3.307

7.  Status epilepticus and anti-NMDA receptor encephalitis after resection of an ovarian teratoma.

Authors:  Amritpal S Jandu; Peter M Odor; Steven D Vidgeon
Journal:  J Intensive Care Soc       Date:  2016-03-18

8.  Case Report: Antibodies to the N-Methyl-D-Aspartate Receptor in a Patient With Multiple Sclerosis.

Authors:  Ran Zhou; Fei Jiang; Haobing Cai; Qiuming Zeng; Huan Yang
Journal:  Front Immunol       Date:  2021-04-23       Impact factor: 7.561

9.  Gerstmann-Straüssler-Scheinker disease: novel PRNP mutation and VGKC-complex antibodies.

Authors:  Matthew Jones; Sola Odunsi; Daniel du Plessis; Angela Vincent; Matthew Bishop; Mark W Head; James W Ironside; David Gow
Journal:  Neurology       Date:  2014-05-09       Impact factor: 9.910

Review 10.  Autoantibodies to central nervous system neuronal surface antigens: psychiatric symptoms and psychopharmacological implications.

Authors:  T A Pollak; K Beck; S R Irani; O D Howes; A S David; P K McGuire
Journal:  Psychopharmacology (Berl)       Date:  2015-12-14       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.